알츠하이머병과 경도인지장애에서의 혈장 섬유소원과 C 반응 단백의 농도
Plasma Fibrinogen and C-Reactive Protein Levels in Alzheimer’s Disease and Mild Cognitive Impairment
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Objective:The aim of this study was to measure and compare the levels of fibrinogen and C-reactive protein (CRP) in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) groups and to investigate the correlations between bloodbased inflammatory factors and cognitive functions. Methods:Seventy one subjects participated in this study [AD : 28, MCI : 23, normal control (NC) : 20]. The overall cognitive function of the subjects and the severity of the disease stage were assessed using Mini-Mental Status Examination in the Korean Version of the the CERAD Assessment Packet (MMSE-KC), Global Deterioration Scale (GDS), Clinical Dementia Rating (CDR), Korean neuropsychiatric inventory (K-NPI) and Geriatric Depression Scale (K-GDS). Plasma fibrinogen and CRP were also measured in AD, MCI, and NC groups. Results:Fibrinogen and CRP levels were not significantly different among AD, MCI, and NC groups. Fibrinogen and CRP did not show a significant correlation with MMSE-KC, CDR, GDS, K-NPI and K-GDS scores. Conclusion:In this study, it was found that plasma fibrinogen and CRP did not increase as cognitive function decreased. But this study was the first meaningful study in Korea about the relationship between cognitive impairment and plasma fibrinogen and CRP levels. It is necessary to conduct prospective cohort studies on more patients in the future.
Abstract
Objective:The aim of this study was to measure and compare the levels of fibrinogen and C-reactive protein (CRP) in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) groups and to investigate the correlations between bloodbased inflammatory factors and cognitive functions. Methods:Seventy one subjects participated in this study [AD : 28, MCI : 23, normal control (NC) : 20]. The overall cognitive function of the subjects and the severity of the disease stage were assessed using Mini-Mental Status Examination in the Korean Version of the the CERAD Assessment Packet (MMSE-KC), Global Deterioration Scale (GDS), Clinical Dementia Rating (CDR), Korean neuropsychiatric inventory (K-NPI) and Geriatric Depression Scale (K-GDS). Plasma fibrinogen and CRP were also measured in AD, MCI, and NC groups. Results:Fibrinogen and CRP levels were not significantly different among AD, MCI, and NC groups. Fibrinogen and CRP did not show a significant correlation with MMSE-KC, CDR, GDS, K-NPI and K-GDS scores. Conclusion:In this study, it was found that plasma fibrinogen and CRP did not increase as cognitive function decreased. But this study was the first meaningful study in Korea about the relationship between cognitive impairment and plasma fibrinogen and CRP levels. It is necessary to conduct prospective cohort studies on more patients in the future.
참고문헌 (35)
- Carlsson CM, "Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer’s disease: future directions", J Alzheimers Dis, 15, pp.327~338 (2008)
- Fratiglioni L, "Epidemiology of Alzheimer’s disease and current possibilities for prevention", Acta Neurol Scand Suppl, 165, pp.33~40 (1996)
- Green RC, "Depression as a risk factor for Alzheimer disease: the MIRAGE Study", Arch Neurol, 60, pp.753~759 (2003)
- Osterweil D, "Cognitive function in non-demented older adults with hypothyroidism", J Am Geriatr Soc, 40, pp.325~335 (1992)
- Letenneur L, "Risk of dementia and alcohol and wine consumption: a review of recent results", Biol Res, 37, pp.189~193 (2004)
- Seshadri S, "Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease", N Engl J Med, 346, pp.476~483 (2002)
- Cummings JL, "Alzheimer disease", JAMA, 287, pp.2335~2338 (2002)
- Swardfager W, "A meta-analysis of cytokines in Alzheimer’s disease", Biol Psychiatry, 68, pp.930~941 (2010)
- Davalos D, "Fibrinogen as a key regulator of inflammation in disease", Semin Immunopathol, 34, pp.43~62 (2012)
- Ryu JK, "leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease b", J Cell Mol Med, 13, pp.2911~2925 (2009)
- Paul J, "Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimerʼs disease", J Exp Med, 204, pp.1999~2008 (2007)
- Cortes-Canteli M, "Fibrinogen, a possible key player in Alzheimer’s disease", J Thromb Haemost, 7(Suppl 1), pp.146~150 (2009)
- Cortes-Canteli M, "Fibrin deposited in the Alzheimer’s disease brain promotes neuronal degeneration", Neurobiol Aging, 36, pp.608~617 (2015)
- Marioni RE, "Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia", Psychosom Med, 71, pp.901~906 (2009)
- Vishnu VY, "Role of inflammatory and hemostatic biomarkers in Alzheimer’s and vascular dementia - A pilot study from a tertiary center in Northern India", Asian J Psychiatr, 29, pp.59~62 (2017)
- Schram MT, "Systemic markers of inflammation and cognitive decline in old age", J Am Geriatr Soc, 55, pp.708~716 (2007)
- Weuve J, "Highsensitivity C-reactive protein and cognitive function in older women", Epidemiology, 17, pp.183~189 (2006)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimerʼs Disease", Neurology, 34, pp.939~944 (1984)
- Petersen RC, "Mild cognitive impairment: a concept in evolution", J Intern Med, 275, pp.214~228 (2014)
- Park JH, "Standardization of Korean version of the mini-mental state examination (MMSE-K) for use in the elderly", J Korean Neuropsychiatr Assoc, 28, pp.508~513 (1989)
- 최성혜, "한국판 Global Deterioration Scale의 타당도", 대한신경과학회지, 20(6), pp.612~617 (2002), 대한신경과학회
- Cummings JL, "The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia", Neurology, 44, pp.2308~2314 (1994)
- Fuh JL, "Behavioral disorders and caregivers’ reaction in Taiwanese patients with Alzheimer’s disease", Int Psychogeriatr, 13, pp.121~128 (2001)
- Hirono N, "Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients", No To Shinkei, 49, pp.266~271 (1997)
- Jung IK, "A reliability and validity study of geriatric depression scale", J Korean Neuropsychiatr Assoc, 36, pp.103~112 (1997)
- Xu G, "Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment", Int J Clin Pract, 62, pp.1070~1075 (2008)
- Wada M, "Plasma fibrinogen, global cognitive function, and cerebral small vessel disease: results of a cross-sectional study in communitydwelling Japanese elderly", Intern Med, 50, pp.999~1007 (2011)
- Van Oijen M, "Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia", Stroke, 36, pp.2637~2641 (2005)
- Cortes-Canteli M, "Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer’s disease", Neuron, 66, pp.695~709 (2010)
- Gabin JM, "The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway", Immun Ageing, 15, pp.4~ (2018)
- Ravaglia G, "Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers", J Gerontol A Biol Sci Med Sci, 60, pp.1017~1021 (2005)
- Watanabe Y, "Elevated C-reactive protein is associated with cognitive decline in outpatients of a general hospital: the project in sado for total health (PROST)", Dement Geriatr Cogn Dis Extra, 6, pp.10~19 (2016)
- Latina JM, "The relationship between obstructive sleep apnea and atrial fibrillation: a complex interplay", Pulm Med, 2013, pp.621736~ (2013)
- Ammitzbøll CG, "CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients", Arthritis Res Ther, 16, pp.475~ (2014)
- Bremner WF, "Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men", Am Heart J, 139, pp.164~173 (2000)
